<?xml version="1.0" encoding="UTF-8"?>
<p>The most potent hybrids on breast cancer cell lines (
 <bold>series 5</bold>) were further evaluated biochemically for their kinase inhibitory activity on CDK-2 and GSK-3Î² using their Kinase Assay Kits, and were compared to the pan-kinase inhibitor staurosporine as a reference standard. The results were presented in 
 <xref rid="t0002" ref-type="table">Table 2</xref>.
</p>
